Mapping Draining Lymph Nodes in CNS Malignancies
NCT04096716
·
clinicaltrials.gov ↗
PHASE1
Phase
TERMINATED
Status
14
Enrollment
OTHER
Sponsor class
Stopped
Insufficient funding/staff
Conditions
Central Nervous System Neoplasms
Central Nervous System Tumor
Interventions
DRUG:
Tc-99m tilmanocept
Sponsor
Washington University School of Medicine
Collaborators
[object Object]